Navigation Links
Perrigo Company to Present at The Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference
Date:7/7/2008

ALLEGAN, Mich., July 7 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced today that Joseph C. Papa, Perrigo's Chairman and CEO will present at the Oppenheimer & Co. Inc. 8th Annual Consumer Growth Conference on Tuesday, July 8, at 4:05 p.m. (ET) at the Four Seasons Hotel in Boston. The presentation will be webcast on the following link http://www.veracast.com/webcasts/opco/consumer08/79112301.cfm

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 2Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 3Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 4Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 5Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2Promising hematologists begin year long program to pursue careers in clinical research 51517 1Promising hematologists begin year long program to pursue careers in clinical research 51517 2Queens University study aims at early diagnosis for ADHD and Parkinsons disease 51513 1Queens University study aims at early diagnosis for ADHD and Parkinsons disease 51513 2Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 1Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 2Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 3Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 4